Your browser doesn't support javascript.
loading
Provider and Site-Level Determinants of Testosterone Prescribing in the Veterans Healthcare System.
Jasuja, Guneet K; Bhasin, Shalender; Rose, Adam J; Reisman, Joel I; Hanlon, Joseph T; Miller, Donald R; Morreale, Anthony P; Pogach, Leonard M; Cunningham, Francesca E; Park, Angela; Wiener, Renda S; Gifford, Allen L; Berlowitz, Dan R.
Affiliation
  • Jasuja GK; Center for Healthcare Organization and Implementation Research (CHOIR), ENRM VAMC, Bedford, Massachusetts 01730.
  • Bhasin S; Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts 02118.
  • Rose AJ; Research Program in Men's Health, Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School Boston, Boston, Massachusetts 02115.
  • Reisman JI; Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Hanlon JT; Center for Healthcare Organization and Implementation Research (CHOIR), ENRM VAMC, Bedford, Massachusetts 01730.
  • Miller DR; Division of Geriatrics, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
  • Morreale AP; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
  • Pogach LM; Center for Health Equity Research and Geriatric Research Education and Clinical Center, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania 15213.
  • Cunningham FE; Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
  • Park A; Center for Healthcare Organization and Implementation Research (CHOIR), ENRM VAMC, Bedford, Massachusetts 01730.
  • Wiener RS; Clinical Pharmacy Services and Healthcare Services Research, VA Pharmacy Benefits Management Services VACO, San Diego, California 92161.
  • Gifford AL; Department of Veterans Affairs, New Jersey Healthcare System, East Orange, New Jersey 07018.
  • Berlowitz DR; VA Pharmacy Benefits Management Services, Hines, Illinois 60141.
J Clin Endocrinol Metab ; 102(9): 3226-3233, 2017 09 01.
Article in En | MEDLINE | ID: mdl-28911150
ABSTRACT
Context Testosterone prescribing rates have increased substantially in the past decade. However, little is known about the context within which such prescriptions occur.

Objective:

We evaluated provider- and site-level determinants of receipt of testosterone and of guideline-concordant testosterone prescribing.

Design:

This study was cross-sectional in design.

Setting:

This study was conducted at the Veterans Health Administration (VA).

Participants:

Study participants were a national cohort of male patients who had received at least one outpatient prescription within the VA during fiscal year (FY) 2008 to FY 2012. A total of 38,648 providers and 130 stations were associated with these patients. Main Outcome

Measure:

This study measured receipt of testosterone and guideline-concordant testosterone prescribing.

Results:

Providers ranging in age from 31 to 60 years, with less experience in the VA [all adjusted odds ratio (AOR), <2; P < 0.01] and credentialed as medical doctors in endocrinology (AOR, 3.88; P < 0.01) and urology (AOR, 1.48; P < 0.01) were more likely to prescribe testosterone compared with older providers, providers of longer VA tenure, and primary care providers, respectively. Sites located in the West compared with the Northeast [AOR, 1.75; 95% confidence interval (CI), 1.45-2.11] and care received at a community-based outpatient clinic compared with a medical center (AOR, 1.22; 95% CI, 1.20-1.24) also predicted testosterone use. Although they were more likely to prescribe testosterone, endocrinologists were also more likely to obtain an appropriate workup before prescribing compared with primary care providers (AOR, 2.14; 95% CI, 1.54-2.97).

Conclusions:

Our results highlight the opportunity to intervene at both the provider and the site levels to improve testosterone prescribing. This study also provides a useful example of how to examine contributions to prescribing variation at different levels of the health care system.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Prescriptions / Testosterone / Health Personnel / Drug Utilization / Hospitals, Veterans Type of study: Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Clin Endocrinol Metab Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Prescriptions / Testosterone / Health Personnel / Drug Utilization / Hospitals, Veterans Type of study: Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Clin Endocrinol Metab Year: 2017 Document type: Article